Jump to Navigation

Research Updates

Research Update

FDA Publishes Article Critical of Vilazodone Data

It has been over a year now since the approval of vilazodone (Viibryd). As you may recall from our review of the drug in TCPR April 2011, vilazodone is an SSRI with partial agonism at the 5HT1A receptor.

How Risky is Pregnancy for Women with a History of Mood Disorders?

We know that the postpartum period is a risky time for women who have a history of depression, especially if they experienced postpartum depression in the past. But several questions about mood and pregnancy are still unanswered.